Navigation Links
Prime Therapeutics Announces CareCentered Contract™ with EMD Serono, Inc. for MS Drug Rebif®
Date:3/7/2012

ST. PAUL, Minn., March 7, 2012 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), and EMD Serono, Inc., a leader in the U.S. biopharmaceutical market and subsidiary of Merck KGaA, Darmstadt, Germany, have entered into an agreement bringing the first outcomes-based rebate contract for a multiple sclerosis (MS) drug to Prime's CareCentered Contracting program. As an integrated PBM with its health plan clients, Prime is uniquely positioned to ensure members are taking effective prescription medications that truly improve their health by evaluating outcomes data throughout the entire length of the contract.

"With more than 57 percent of the direct health care costs to treat MS in the United States related to drug expenses, it is important to focus on medication adherence and cost effectiveness to ensure the greatest health benefit for each dollar spent," said Peter Wickersham, senior vice president of cost of care at Prime. "Our CareCentered Contract with EMD Serono goes beyond outcomes to do just that. It includes the total cost of care component, inclusive of medical and pharmacy costs and medication adherence."

The contract, which began January 1, stipulates that EMD Serono will pay rebates to Prime on the utilization of Rebif (interferon beta-1a) if patients who are on the drug have a higher overall total cost to their plans than patients on a different MS drug, or if the medication adherence rate remains above a specified level. Prime will evaluate data pertaining to the health outcomes and medication adherence of patients a number of times throughout the contract in order to determine the total cost of care, including medical and pharmacy costs.

"Enabling excellent patient and payer outcomes is more important than ever for biopharmaceutical manufacturers in today's health care environment," said Mike Dezelan, senior vice president of managed markets at EMD Serono. "Our innovative contract with Prime will bring greater focus to patient adherence, which we expect will help keep hospitalization and emergency visits to a minimum and maximize cost effectiveness."

Traditionally, pharmaceutical rebate contracts negotiated by PBMs were based solely on the volume of drugs purchased. As growing numbers of high-cost specialty products enter the market, drug manufacturers are being asked to substantiate the value their medications can provide when taken appropriately, such as keeping patients out of the hospital and slowing disease progression. As an integrated PBM, Prime is uniquely able to evaluate these health outcomes by coordinating pharmacy and medical data for its health plan owners.

The Rebif agreement with EMD Serono is the third CareCentered Contract that Prime has entered into with pharmaceutical partners in the last 12 months. Other chronic diseases of focus thus far have included osteoporosis and diabetes.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 20 million* covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.

*Effective 4/1/12

 


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Twin Med, LLC Acquires Medical Supply Distributor PrimeCare
2. BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne™ Leukemia Vaccine
3. PrimeraDx Appoints David Jackson as VP of Business Development
4. Solos Endoscopy, Inc. is Primed for Growth in 2012
5. PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board
6. H. D. Smith and Adventist Health System Sign Prime Vendor Agreement
7. PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development
8. Prime Therapeutics Launches Retail Medication Therapy Management Program
9. Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs
10. Prime Therapeutics Launches CareCentered Contracting™ Program
11. Wasatch Pediatrics Selects Phreesia and Greenway PrimeSUITE to Streamline its Workflow and Increase Cash Flow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):